Literature DB >> 16004965

Functional impairment of telomerase in sublines derived from human lung adenocarcinoma exposed to mild oxidative stress.

Yoshinori Katakura1, Kaichi Yoshizaki, Tomoharu Yasuda, Takahiro Tsunematsu, Norihisa Uehara, Takumi Miura, Tsukasa Fujiki, Sanetaka Shirahata.   

Abstract

We investigated the effects of a sublethal concentration of H(2)O(2) on cancer cells by using sublines derived from human lung adenocarcinoma cell line A549 cells exposed to 200 microM H(2)O(2). These sublines (AST cells) showed an elongated morphology distinct from the rounded morphology of A549 cells. Notably, AST cells demonstrated telomere shortening despite displaying telomerase activity and expressing human telomerase reverse transcriptase (hTERT). This functional impairment of telomerase occurred due to perturbed subcellular localization of hTERT in AST cells. Endogenous as well as ectopically expressed hTERT was localized in the nuclei of A549 cells; however, in AST cells, the localization was mainly in the cytoplasm. Furthermore, these AST cells demonstrated decreased tumorigenic features both in vitro and in vivo. These results suggest that depletion of hTERT from nuclei not only endows cancer cells with a finite replicative life span accompanied by telomere shortening, but also decreases the tumorigenicity of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004965     DOI: 10.1016/j.bbrc.2005.06.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.

Authors:  Joana Soares; Brian R Keppler; Xihong Wang; Kuo-Hsiung Lee; Michael B Jarstfer
Journal:  Bioorg Med Chem Lett       Date:  2011-10-08       Impact factor: 2.823

2.  Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.

Authors:  Mirko Tarocchi; Simone Polvani; Anna Julie Peired; Giada Marroncini; Massimo Calamante; Elisabetta Ceni; Daniela Rhodes; Tommaso Mello; Giuseppe Pieraccini; Alessandro Quattrone; Claudio Luchinat; Andrea Galli
Journal:  J Hepatol       Date:  2014-05-23       Impact factor: 25.083

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.